title: Anti-Ri antibody associated small cell lung carcinoma.
abstract: BACKGROUND
  Anti-neuronal antibody Anti-Ri may be positive in patients with paraneoplastic syndrome associated with certain cancer subtypes. Anti-Ri positivity has been associated with breast, gynaecological and small cell lung cancers.
  
  
  METHODS
  A 69 year-old female presented with a sudden decline in cognition requiring hospital admission. She had an extensive medical history including a significant smoking history and bipolar affective disorder for which she was prescribed lithium. Her cognitive decline was initially attributed to diabetes insipidus secondary to lithium therapy. She made a slow but gradual recovery with treatment. Additional investigations revealed positive Anti-Ri antibody. An occult malignancy screen identified enlarged aorto-pulmonary lymph nodes of indeterminate significance. Following discussion at the regional cardiothoracic multidisciplinary team meeting, three monthly surveillance scans were performed. At month 6 an increase in thoracic adenopathy was seen however endobronchial ultrasound guided biopsy failed to identify malignant cells. Further progression with new supraclavicular adenopathy was seen on repeat imaging 6 months later. A fine need aspirate of an enlarged supraclavicular lymph node was diagnostic for small cell lung cancer, staged as TxN3M0 on positron emission tomography. The patient went on to receive sequential chemo-radiotherapy with a truncated course of carboplatin and etoposide and 50 Gy/25 fractions of thoracic radiotherapy.
  
  
  CONCLUSIONS
  This case suggests that a positive Anti-Ri antibody may predate the development of clinical or radiological evidence of malignancy. If Anti-Ri positivity is identified, strong consideration should be given to screening for malignancy and regular surveillance. This approach may lead to earlier diagnosis and a better outcome for these patients.
authors.affiliation: Department of Medical Oncology, Mercy University Hospital, Cork, Ireland. connorgoleary@gmail.com.|Department of Medical Oncology, Cork University Hospital, Cork, Ireland. connorgoleary@gmail.com.
authors.forename: C G
authors.initials: CG
authors.lastname: O'Leary
authors.affiliation: Department of Medical Oncology, Mercy University Hospital, Cork, Ireland.|Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
authors.forename: J E
authors.initials: JE
authors.lastname: Battley
authors.affiliation: Department of Medical Oncology, Mercy University Hospital, Cork, Ireland.|Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
authors.forename: S
authors.initials: S
authors.lastname: O'Reilly
mesh_terms: D000368:Aged; D000906:Antibodies / Q000276:immunology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology* / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D049268:Positron-Emission Tomography; D055752:Small Cell Lung Carcinoma / Q000276:immunology* / Q000473:pathology
chemical_list: D000906:Antibodies
keywords: Anti neuronal antibody; Anti-Ri antibody; Cognitive decline; Lung cancer; Small cell lung cancer; Small cell lung carcinoma
references.citation: Ann Neurol. 1991 Mar;29(3):241-51
references.pmid: 2042940
references.citation: Ulster Med J. 2010 Jan;79(1):22-4
references.pmid: 20844728
references.citation: J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):940-3
references.pmid: 2178180
references.citation: J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii43-50
references.pmid: 15146039
references.citation: Arch Neurol. 2012 Dec;69(12):1598-607
references.pmid: 22986354
references.citation: J R Coll Physicians Edinb. 2012;42(3):221-4
references.pmid: 22953316